D-0349-2019 Class III Terminated
FDA drug recall D-0349-2019 was initiated by Glenmark Pharmaceuticals Inc., USA on Nov 27, 2018 and is designated Class III. Reason for recall: Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack. The recall status is terminated (terminated Sep 12, 2019). Affected quantity: 5,016 blister packs.
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 26, 2018
- Initiation Date
- Nov 27, 2018
- Termination Date
- Sep 12, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,016 blister packs
Product Description
Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40
Reason for Recall
Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.
Distribution Pattern
Nationwide
Code Information
Lot: 17180918, EXP June 2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0349-2019
- openFDA file date
- Oct 21, 2026
- Loaded by RegDataLab
- Oct 23, 2026